PMID- 21074396 OWN - NLM STAT- MEDLINE DCOM- 20110414 LR - 20151119 IS - 1873-4235 (Electronic) IS - 0956-5663 (Linking) VI - 26 IP - 5 DP - 2011 Jan 15 TI - Fabrication of stable antibody-modified field effect transistors using electrical activation of Schiff base cross-linkages for tumor marker detection. PG - 2419-25 LID - 10.1016/j.bios.2010.10.023 [doi] AB - In this paper, we present a method of fabricating a rigid antibody-immobilized surface using electric activation of a glutaraldehyde (GA)-modified aminopropylsilyl surface for stable antibody-modified field effect transistors (FETs). Electric activation of the GA-modified gate surface of the FET reduces Schiff bases, which are easily hydrolyzed and collapsed, formed between GA and 3-aminopropyltriethoxysilane, resulting in preventing the immobilized antibodies from desorbing from the surface. The lack of Raman peaks that could be assigned to a Schiff base after the electrical activation of the GA-modified surface indicated that the electric activation had reduced the Schiff base. The use of the antibody-modified FETs has three advantages for the detection of antigens: increased sensitivity, distinct recognition ability, and improved reproducibility. A tumor marker, alpha-fetoprotein (AFP), was quantitatively detected up to a concentration of 10 ng/mL using the antibody-modified FET. The detection ability of the FET accomplished a cutoff value of hepatic cancer. The quantitative detection of AFP in a solution with contaminating proteins was also demonstrated. This electric activation method is applicable to other antibody-modified FETs. CI - Copyright A(c) 2010 Elsevier B.V. All rights reserved. FAU - Hideshima, Sho AU - Hideshima S AD - Department of Applied Chemistry, Faculty of Science and Engineering, Waseda University, Okubo 3-4-1, Shinjuku-ku, Tokyo 169-8555, Japan. FAU - Sato, Ryosuke AU - Sato R FAU - Kuroiwa, Shigeki AU - Kuroiwa S FAU - Osaka, Tetsuya AU - Osaka T LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20101020 PL - England TA - Biosens Bioelectron JT - Biosensors & bioelectronics JID - 9001289 RN - 0 (Antibodies, Neoplasm) RN - 0 (Biomarkers, Tumor) RN - 0 (Cross-Linking Reagents) RN - 0 (Gonadotropins) RN - 0 (Schiff Bases) RN - 0 (alpha-Fetoproteins) SB - IM MH - Antibodies, Neoplasm/chemistry/immunology MH - Biomarkers, Tumor/*analysis MH - Biosensing Techniques/*instrumentation MH - Conductometry/*instrumentation MH - Cross-Linking Reagents/chemistry MH - Equipment Design MH - Equipment Failure Analysis MH - Gonadotropins/*analysis/chemistry/immunology MH - Humans MH - Liver Neoplasms/diagnosis/*metabolism MH - Schiff Bases/chemistry MH - *Transistors, Electronic MH - Tumor Cells, Cultured MH - alpha-Fetoproteins/*analysis/chemistry/immunology EDAT- 2010/11/16 06:00 MHDA- 2011/04/16 06:00 CRDT- 2010/11/16 06:00 PHST- 2010/07/07 00:00 [received] PHST- 2010/10/12 00:00 [revised] PHST- 2010/10/13 00:00 [accepted] PHST- 2010/11/16 06:00 [entrez] PHST- 2010/11/16 06:00 [pubmed] PHST- 2011/04/16 06:00 [medline] AID - S0956-5663(10)00708-6 [pii] AID - 10.1016/j.bios.2010.10.023 [doi] PST - ppublish SO - Biosens Bioelectron. 2011 Jan 15;26(5):2419-25. doi: 10.1016/j.bios.2010.10.023. Epub 2010 Oct 20.